Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Evaluating the correlation between film mammography and MRI for screening women with increased breast cancer risk.

Lee JM, Halpern EF, Rafferty EA, Gazelle GS.

Acad Radiol. 2009 Nov;16(11):1323-8. doi: 10.1016/j.acra.2009.05.011. Epub 2009 Jul 25. Review.

2.

Implementation of digital mammography in a population-based breast cancer screening program: effect of screening round on recall rate and cancer detection.

Sala M, Comas M, Macià F, Martinez J, Casamitjana M, Castells X.

Radiology. 2009 Jul;252(1):31-9. doi: 10.1148/radiol.2521080696. Epub 2009 May 6.

PMID:
19420316
3.

A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer.

Lord SJ, Lei W, Craft P, Cawson JN, Morris I, Walleser S, Griffiths A, Parker S, Houssami N.

Eur J Cancer. 2007 Sep;43(13):1905-17. Epub 2007 Aug 2. Review.

PMID:
17681781
4.

MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.

Granader EJ, Dwamena B, Carlos RC.

Acad Radiol. 2008 Dec;15(12):1590-5. doi: 10.1016/j.acra.2008.06.006.

PMID:
19000876
5.

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.

Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D.

Ann Intern Med. 2008 May 6;148(9):671-9. Review.

PMID:
18458280
6.

Added cancer yield of breast magnetic resonance imaging screening in women with a prior history of chest radiation therapy.

Freitas V, Scaranelo A, Menezes R, Kulkarni S, Hodgson D, Crystal P.

Cancer. 2013 Feb 1;119(3):495-503. doi: 10.1002/cncr.27771. Epub 2012 Sep 5.

7.

The positive predictive value for diagnosis of breast cancer full-field digital mammography versus film-screen mammography in the diagnostic mammographic population.

Seo BK, Pisano ED, Kuzmiak CM, Koomen M, Pavic D, McLelland R, Lee Y, Cole EB, Mattingly D, Lee J.

Acad Radiol. 2006 Oct;13(10):1229-35.

PMID:
16979072
8.

Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.

Lehman CD, Blume JD, Weatherall P, Thickman D, Hylton N, Warner E, Pisano E, Schnitt SJ, Gatsonis C, Schnall M, DeAngelis GA, Stomper P, Rosen EL, O'Loughlin M, Harms S, Bluemke DA; International Breast MRI Consortium Working Group.

Cancer. 2005 May 1;103(9):1898-905.

9.

Serendipity in diagnostic imaging: magnetic resonance imaging of the breast.

Lawrence WF, Liang W, Mandelblatt JS, Gold KF, Freedman M, Ascher SM, Trock BJ, Chang P.

J Natl Cancer Inst. 1998 Dec 2;90(23):1792-800.

PMID:
9839519
10.

Patterns of breast magnetic resonance imaging use in community practice.

Wernli KJ, DeMartini WB, Ichikawa L, Lehman CD, Onega T, Kerlikowske K, Henderson LM, Geller BM, Hofmann M, Yankaskas BC; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2014 Jan;174(1):125-32. doi: 10.1001/jamainternmed.2013.11963.

11.

Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma.

Ng AK, Garber JE, Diller LR, Birdwell RL, Feng Y, Neuberg DS, Silver B, Fisher DC, Marcus KJ, Mauch PM.

J Clin Oncol. 2013 Jun 20;31(18):2282-8. doi: 10.1200/JCO.2012.46.5732. Epub 2013 Apr 22.

PMID:
23610104
12.

Breast cancer risk assessment in 64,659 women at a single high-volume mammography clinic.

Brinton JT, Barke LD, Freivogel ME, Jackson S, O'Donnell CI, Glueck DH.

Acad Radiol. 2012 Jan;19(1):95-9. doi: 10.1016/j.acra.2011.09.003. Epub 2011 Nov 3.

13.

Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.

Stoutjesdijk MJ, Boetes C, Jager GJ, Beex L, Bult P, Hendriks JH, Laheij RJ, Massuger L, van Die LE, Wobbes T, Barentsz JO.

J Natl Cancer Inst. 2001 Jul 18;93(14):1095-102.

PMID:
11459871
14.

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.

Saadatmand S, Tilanus-Linthorst MM, Rutgers EJ, Hoogerbrugge N, Oosterwijk JC, Tollenaar RA, Hooning M, Loo CE, Obdeijn IM, Heijnsdijk EA, de Koning HJ.

J Natl Cancer Inst. 2013 Sep 4;105(17):1314-21. doi: 10.1093/jnci/djt203. Epub 2013 Aug 12.

PMID:
23940285
15.

The role of magnetic resonance imaging in screening women at high risk of breast cancer.

Warner E.

Top Magn Reson Imaging. 2008 Jun;19(3):163-9. doi: 10.1097/RMR.0b013e31818bc994. Review.

PMID:
18941396
16.

The use of magnetic resonance imaging in breast cancer screening.

Lee CH, Weinreb JC.

J Am Coll Radiol. 2004 Mar;1(3):176-82. Review.

PMID:
17411555
17.

Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.

Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, König R, Tombach B, Leutner C, Rieber-Brambs A, Nordhoff D, Heindel W, Reiser M, Schild HH.

J Clin Oncol. 2010 Mar 20;28(9):1450-7. doi: 10.1200/JCO.2009.23.0839. Epub 2010 Feb 22.

PMID:
20177029
18.
19.

Magnetic resonance imaging as a diagnostic tool for breast cancer in premenopausal women.

Wright H, Listinsky J, Rim A, Chellman-Jeffers M, Patrick R, Rybicki L, Kim J, Crowe J.

Am J Surg. 2005 Oct;190(4):572-5.

PMID:
16164923
20.

Developing asymmetry identified on mammography: correlation with imaging outcome and pathologic findings.

Leung JW, Sickles EA.

AJR Am J Roentgenol. 2007 Mar;188(3):667-75.

PMID:
17312052

Supplemental Content

Support Center